中西医结合治疗慢性乙型肝炎175例观察（Observation on 175 cases of chronic hepatitis B treated with combination of TCM and Western Medicine）.docVIP

中西医结合治疗慢性乙型肝炎175例观察（Observation on 175 cases of chronic hepatitis B treated with combination of TCM and Western Medicine） Observation on 175 cases of chronic hepatitis B treated with combination of TCM and Western Medicine Update Date: 2011-04-09 hits: Li Qiming, Jin Yisheng, Chen Zijian, Zhang Chunping, Zhang Bingxue, Wang Xiaoqing, Lou Manna In order to invigorate the circulation of blood stasis, the traditional Chinese medicine combined with western medicine symptomatic support for treatment of chronic hepatitis B 175 cases, the average treatment of 60.86 + 11.53 D, the total effective rate of 88.57%, significantly better than the control group 68.82% (P 0.05). Compared with the control group, the observation group was significantly superior to the control group (P 0.01) in decreasing ALT, elevating plasma albumin and regulating the ratio of white globulin. HBeAg negative conversion rate and anti -HBe positive rate were also significantly different between the two groups (P 0.05). That in the observation group to inhibit the replication of HBV, promote the anti -BHe seroconversion is better than the control group; from the determination of immune function, increase the observation group average E-RFC after treatment, IgG decreased, with statistical significance, suggesting that the immune function of patients with the disorder have a regulatory role. The average number of treatment days was also significantly shorter in the observation group than in the control group (P 0.01). No side effects were found during the medication. After 2 years of follow-up observation, there were 1 cases of cirrhosis in the observation group, 7 cases of cirrhosis in the control group, 2 cases died of liver failure, the difference between the two groups was significant (P 0.01). Keywords chronic hepatitis B; promoting blood circulation and removing blood stasis; Chinese medicine treatment; western medicine symptomatic support therapy; The incidence of liver fibrosis in chronic he